Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

NASDAQ:GILD

Overview | Financials
Company Name Gilead Sciences, Inc.
Symbol GILD
Currency USD
Price 115.88
Market Cap 143,785,062,800
Dividend Yield 4.46%
52-week-range 78.36 - 121.83
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Daniel P. O'Day
Website https://www.gilead.com

An error occurred while fetching data.

About Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,

Related Stocks

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

470 USD

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

558.44 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

395.25 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

24.83 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

98.18 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.98 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

652.83 USD

Biogen Inc. logo

Biogen Inc.

BIIB

141.35 USD

Financials

Numbers are in millions USD

Numbers are in millions USD